Prostaglandins, Leukotrienes and Essential Fatty Acids
Volume 70, Issue 4 , Pages 357-360 , April 2004

In vivo MR spectroscopy in diagnosis and research of neuropsychiatric disorders

  • I.J Cox

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +44-20-8383-3298; fax: +44-20-8383-3038
    • ,
  • B.K Puri

,Accepted 18 December 2003.

References 

  1. Cady EB. Quantitative combined phosphorus and proton PRESS of the brains of newborn human infants. Magn. Reson. Med. 1995;33:557–563
  2. E.B. Cady, A.M. Costello, M.J. Dawson, D.T. Delpy, P.L. Hope, E.O. Reynolds, P.S. Tofts, D.R. Wilkie, Non-invasive investigation of cerebral metabolism in newborn infants by phosphorus nuclear magnetic resonance spectroscopy, Lancet 1(8333) (1983) 1059–1062.
  3. Cox IJ. Development and applications of in vivo clinical magnetic resonance spectroscopy. Prog. Biophys. Mol. Biol. 1996;65:45–81
  4. S.C. Roth, A.D. Edwards, E.B. Cady, D.T. Delpy, J.S. Wyatt, D. Azzopardi, J. Baudin, J. Townsend, A.L. Stewart, E.O.R. Reynolds, Relation between cerebral oxidative metabolism following birth asphyxia and neurodevelopmental outcome and brain growth at one year, Dev. Med. Child Neurol. 34 (1992) 285–295.
  5. Robertson NJ, Cowan FM, Cox IJ, Edwards AD. Brain alkaline intracellular pH after neonatal encephalopathy. Ann. Neurol. 2002;52:732–742
  6. Taylor DL, Edwards AD, Mehmet H. Oxidative metabolism, apoptosis and perinatal brain injury. Brain Pathol. 1999;9:93–117
  7. Pettegrew JW, Keshavan MS, Panchalingam K, Strychor S, Kaplan DB, Tretta MG, et al. Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy. Arch. Gen Psychiatry. 1991;48:563–568
  8. Keshavan MS, Pettegrew JW, Panchalingam KS, Kaplan D, Bozik E. Phosphorus 31 magnetic resonance spectroscopy detects altered brain metabolism before onset of schizophrenia. Arch. Gen Psychiatry. 1991;48:1112–1113
  9. Williamson P, Drost D, Stanley J, Carr T, Morrison S, Merskey H. Localized phosphorus 31 magnetic resonance spectroscopy in chronic schizophrenic patients and normal controls. Arch. Gen Psychiatry. 1991;48:578
  10. Stanley JA, Williamson PC, Drost DJ, Carr TJ, Rylett RJ, Malla A, et al. An in vivo study of the prefrontal cortex of schizophrenic patients at different stages of illness via phosphorus magnetic resonance spectroscopy. Arch. Gen Psychiatry. 1995;52:399–406
  11. Fukuzako H, Fukuzako T, Hashiguchi T, Kodama S, Takigawa M, Fujimoto T. Changes in levels of phosphorus metabolites in temporal lobes of drug-naive schizophrenic patients. Am. J. Psychiatry. 1999;156:1205–1208
  12. Pettegrew JW, Keshavan MS, Stanley JA, McClure RJ, Johnson CR, Panchalingam K. Magnetic resonance spectroscopy in the assessment of phospholipid metabolism in schizophrenia and other psychiatric disorders. In:  Peet M,  Glen I,  Horrobin DF editor. Phospholipid Spectrum Disorders in Psychiatry and Neurology. 2nd Edition. Carnforth, Lancashire: Marius Press; 2003;p. 239–255
  13. Puri BK, Richardson AJ, Horrobin DF, Easton T, Saeed N, Oatridge A, et al. Eicosapentaenoic acid treatment in schizophrenia associated with symptom remission, normalisation of blood fatty acids, reduced neuronal membrane phospholipid turnover and structural brain changes. Int. J. Clin. Pract. 2000;54:57–63
  14. Puri BK. MRI and MRS in neuropsychiatry. In:  Young IR,  Grant DM,  Harris RK editor. Methods in Biomedical Magnetic Resonance Imaging and Spectroscopy. New York: Wiley; 2000;p. 1135–1143
  15. Richardson AJ, Cox IJ, Sargentoni J, Puri BK. Abnormal cerebral phospholipid metabolism in dyslexia indicated by phosphorus-31 magnetic resonance spectroscopy. NMR Biomed. 1997;10:309–314
  16. Richardson AJ, Allen SJ, Hajnal JV, Cox IJ, Easton T, Puri BK. Associations between central and peripheral measures of phospholipid breakdown revealed by cerebral 31-phosphorus magnetic resonance spectroscopy and fatty acid composition of erythrocyte membranes. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2001;25:1513–1521
  17. Rae C, Lee MA, Dixon RM, et al.  Metabolic abnormalities in developmental dyslexia detected by 1H magnetic resonance spectroscopy. Lancet. 1998;351:1849–1852
  18. Puri BK, Richardson AJ. Brain phospholipid metabolism in dyslexia assessed by magnetic resonance spectroscopy. In:  Peet M,  Glen I,  Horrobin DF editor. Phospholipid Spectrum Disorders in Psychiatry and Neurology. 2nd Edition. Carnforth Lancashire: Marius Press; 2003;p. 501–508
  19. Puri BK, Counsell SJ, Zaman R, Main J, Collins AG, Hajnal JV, et al. Relative increase in choline in the occipital cortex in chronic fatigue syndrome. Acta Psychiatr. Scand. 2002;106:224–226
  20. Ruiz-Cabello J, Cohen JS. Phospholipid metabolites as indicators of cancer cell function. NMR Biomed. 1992;5:226–233
  21. Chaudhuri A, Condon BR, Gow JW, Brennan D, Hadley DM. Proton magnetic resonance spectroscopy of basal ganglia in chronic fatigue syndrome. Neuroreport. 2003;14:225–228

PII: S0952-3278(04)00006-7

doi: 10.1016/j.plefa.2003.12.010

Prostaglandins, Leukotrienes and Essential Fatty Acids
Volume 70, Issue 4 , Pages 357-360 , April 2004

Article Tools